Global Epilepsy Market Growth (Status and Outlook) 2025-2031

September 2025 | 114 pages | ID: G465BC1D0D0EEN
LP Information

Abstracts

According to this study, the global Epilepsy market size will reach US$ million by 2031.

United States market for Epilepsy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Epilepsy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Epilepsy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Epilepsy players cover LivaNova, Johnson & Johnson Services, Eisai, GlaxoSmithKline PLC, Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Epilepsy Industry Forecast” looks at past sales and reviews total world Epilepsy sales in 2024, providing a comprehensive analysis by region and market sector of projected Epilepsy sales for 2025 through 2031. With Epilepsy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Epilepsy industry.

This Insight Report provides a comprehensive analysis of the global Epilepsy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Epilepsy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Epilepsy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Epilepsy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Epilepsy.

This report presents a comprehensive overview, market shares, and growth opportunities of Epilepsy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Partial/focal Seizure
• Generalized Seizure
• Myoclonus Misses
• Negative Myoclonus
• Eyelid Myoclonus
• Laughter
• Others

Segmentation by Application:

• Hospitals
• Neurology Centers
• Home Care Settings
• Ambulatory Surgical Centers
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• LivaNova
• Johnson & Johnson Services
• Eisai
• GlaxoSmithKline PLC
• Pfizer
• UCB SA
• Medtronic PLC (Ireland)
• NeuroPace
• Novartis AG
• GW Pharmaceuticals
• Abbott Laboratories
• Sanofi
• Sunovion Pharmaceuticals
• Bausch Health
• Takeda

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Epilepsy Market Size (2020-2031)
  2.1.2 Epilepsy Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Epilepsy by Country/Region (2020, 2024 & 2031)
2.2 Epilepsy Segment by Type
  2.2.1 Partial/focal Seizure
  2.2.2 Generalized Seizure
  2.2.3 Myoclonus Misses
  2.2.4 Negative Myoclonus
  2.2.5 Eyelid Myoclonus
  2.2.6 Laughter
  2.2.7 Others
2.3 Epilepsy Market Size by Type
  2.3.1 Epilepsy Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Epilepsy Market Size Market Share by Type (2020-2025)
2.4 Epilepsy Segment by Application
  2.4.1 Hospitals
  2.4.2 Neurology Centers
  2.4.3 Home Care Settings
  2.4.4 Ambulatory Surgical Centers
  2.4.5 Others
2.5 Epilepsy Market Size by Application
  2.5.1 Epilepsy Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Epilepsy Market Size Market Share by Application (2020-2025)

3 EPILEPSY MARKET SIZE BY PLAYER

3.1 Epilepsy Market Size Market Share by Player
  3.1.1 Global Epilepsy Revenue by Player (2020-2025)
  3.1.2 Global Epilepsy Revenue Market Share by Player (2020-2025)
3.2 Global Epilepsy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 EPILEPSY BY REGION

4.1 Epilepsy Market Size by Region (2020-2025)
4.2 Global Epilepsy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Epilepsy Market Size Growth (2020-2025)
4.4 APAC Epilepsy Market Size Growth (2020-2025)
4.5 Europe Epilepsy Market Size Growth (2020-2025)
4.6 Middle East & Africa Epilepsy Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Epilepsy Market Size by Country (2020-2025)
5.2 Americas Epilepsy Market Size by Type (2020-2025)
5.3 Americas Epilepsy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Epilepsy Market Size by Region (2020-2025)
6.2 APAC Epilepsy Market Size by Type (2020-2025)
6.3 APAC Epilepsy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Epilepsy Market Size by Country (2020-2025)
7.2 Europe Epilepsy Market Size by Type (2020-2025)
7.3 Europe Epilepsy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Epilepsy by Region (2020-2025)
8.2 Middle East & Africa Epilepsy Market Size by Type (2020-2025)
8.3 Middle East & Africa Epilepsy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL EPILEPSY MARKET FORECAST

10.1 Global Epilepsy Forecast by Region (2026-2031)
  10.1.1 Global Epilepsy Forecast by Region (2026-2031)
  10.1.2 Americas Epilepsy Forecast
  10.1.3 APAC Epilepsy Forecast
  10.1.4 Europe Epilepsy Forecast
  10.1.5 Middle East & Africa Epilepsy Forecast
10.2 Americas Epilepsy Forecast by Country (2026-2031)
  10.2.1 United States Market Epilepsy Forecast
  10.2.2 Canada Market Epilepsy Forecast
  10.2.3 Mexico Market Epilepsy Forecast
  10.2.4 Brazil Market Epilepsy Forecast
10.3 APAC Epilepsy Forecast by Region (2026-2031)
  10.3.1 China Epilepsy Market Forecast
  10.3.2 Japan Market Epilepsy Forecast
  10.3.3 Korea Market Epilepsy Forecast
  10.3.4 Southeast Asia Market Epilepsy Forecast
  10.3.5 India Market Epilepsy Forecast
  10.3.6 Australia Market Epilepsy Forecast
10.4 Europe Epilepsy Forecast by Country (2026-2031)
  10.4.1 Germany Market Epilepsy Forecast
  10.4.2 France Market Epilepsy Forecast
  10.4.3 UK Market Epilepsy Forecast
  10.4.4 Italy Market Epilepsy Forecast
  10.4.5 Russia Market Epilepsy Forecast
10.5 Middle East & Africa Epilepsy Forecast by Region (2026-2031)
  10.5.1 Egypt Market Epilepsy Forecast
  10.5.2 South Africa Market Epilepsy Forecast
  10.5.3 Israel Market Epilepsy Forecast
  10.5.4 Turkey Market Epilepsy Forecast
10.6 Global Epilepsy Forecast by Type (2026-2031)
10.7 Global Epilepsy Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Epilepsy Forecast

11 KEY PLAYERS ANALYSIS

11.1 LivaNova
  11.1.1 LivaNova Company Information
  11.1.2 LivaNova Epilepsy Product Offered
  11.1.3 LivaNova Epilepsy Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 LivaNova Main Business Overview
  11.1.5 LivaNova Latest Developments
11.2 Johnson & Johnson Services
  11.2.1 Johnson & Johnson Services Company Information
  11.2.2 Johnson & Johnson Services Epilepsy Product Offered
  11.2.3 Johnson & Johnson Services Epilepsy Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Johnson & Johnson Services Main Business Overview
  11.2.5 Johnson & Johnson Services Latest Developments
11.3 Eisai
  11.3.1 Eisai Company Information
  11.3.2 Eisai Epilepsy Product Offered
  11.3.3 Eisai Epilepsy Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Eisai Main Business Overview
  11.3.5 Eisai Latest Developments
11.4 GlaxoSmithKline PLC
  11.4.1 GlaxoSmithKline PLC Company Information
  11.4.2 GlaxoSmithKline PLC Epilepsy Product Offered
  11.4.3 GlaxoSmithKline PLC Epilepsy Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 GlaxoSmithKline PLC Main Business Overview
  11.4.5 GlaxoSmithKline PLC Latest Developments
11.5 Pfizer
  11.5.1 Pfizer Company Information
  11.5.2 Pfizer Epilepsy Product Offered
  11.5.3 Pfizer Epilepsy Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Pfizer Main Business Overview
  11.5.5 Pfizer Latest Developments
11.6 UCB SA
  11.6.1 UCB SA Company Information
  11.6.2 UCB SA Epilepsy Product Offered
  11.6.3 UCB SA Epilepsy Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 UCB SA Main Business Overview
  11.6.5 UCB SA Latest Developments
11.7 Medtronic PLC (Ireland)
  11.7.1 Medtronic PLC (Ireland) Company Information
  11.7.2 Medtronic PLC (Ireland) Epilepsy Product Offered
  11.7.3 Medtronic PLC (Ireland) Epilepsy Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Medtronic PLC (Ireland) Main Business Overview
  11.7.5 Medtronic PLC (Ireland) Latest Developments
11.8 NeuroPace
  11.8.1 NeuroPace Company Information
  11.8.2 NeuroPace Epilepsy Product Offered
  11.8.3 NeuroPace Epilepsy Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 NeuroPace Main Business Overview
  11.8.5 NeuroPace Latest Developments
11.9 Novartis AG
  11.9.1 Novartis AG Company Information
  11.9.2 Novartis AG Epilepsy Product Offered
  11.9.3 Novartis AG Epilepsy Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Novartis AG Main Business Overview
  11.9.5 Novartis AG Latest Developments
11.10 GW Pharmaceuticals
  11.10.1 GW Pharmaceuticals Company Information
  11.10.2 GW Pharmaceuticals Epilepsy Product Offered
  11.10.3 GW Pharmaceuticals Epilepsy Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 GW Pharmaceuticals Main Business Overview
  11.10.5 GW Pharmaceuticals Latest Developments
11.11 Abbott Laboratories
  11.11.1 Abbott Laboratories Company Information
  11.11.2 Abbott Laboratories Epilepsy Product Offered
  11.11.3 Abbott Laboratories Epilepsy Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Abbott Laboratories Main Business Overview
  11.11.5 Abbott Laboratories Latest Developments
11.12 Sanofi
  11.12.1 Sanofi Company Information
  11.12.2 Sanofi Epilepsy Product Offered
  11.12.3 Sanofi Epilepsy Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Sanofi Main Business Overview
  11.12.5 Sanofi Latest Developments
11.13 Sunovion Pharmaceuticals
  11.13.1 Sunovion Pharmaceuticals Company Information
  11.13.2 Sunovion Pharmaceuticals Epilepsy Product Offered
  11.13.3 Sunovion Pharmaceuticals Epilepsy Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Sunovion Pharmaceuticals Main Business Overview
  11.13.5 Sunovion Pharmaceuticals Latest Developments
11.14 Bausch Health
  11.14.1 Bausch Health Company Information
  11.14.2 Bausch Health Epilepsy Product Offered
  11.14.3 Bausch Health Epilepsy Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Bausch Health Main Business Overview
  11.14.5 Bausch Health Latest Developments
11.15 Takeda
  11.15.1 Takeda Company Information
  11.15.2 Takeda Epilepsy Product Offered
  11.15.3 Takeda Epilepsy Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 Takeda Main Business Overview
  11.15.5 Takeda Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Epilepsy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Epilepsy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Partial/focal Seizure
Table 4. Major Players of Generalized Seizure
Table 5. Major Players of Myoclonus Misses
Table 6. Major Players of Negative Myoclonus
Table 7. Major Players of Eyelid Myoclonus
Table 8. Major Players of Laughter
Table 9. Major Players of Others
Table 10. Epilepsy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Epilepsy Market Size by Type (2020-2025) & ($ millions)
Table 12. Global Epilepsy Market Size Market Share by Type (2020-2025)
Table 13. Epilepsy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 14. Global Epilepsy Market Size by Application (2020-2025) & ($ millions)
Table 15. Global Epilepsy Market Size Market Share by Application (2020-2025)
Table 16. Global Epilepsy Revenue by Player (2020-2025) & ($ millions)
Table 17. Global Epilepsy Revenue Market Share by Player (2020-2025)
Table 18. Epilepsy Key Players Head office and Products Offered
Table 19. Epilepsy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Epilepsy Market Size by Region (2020-2025) & ($ millions)
Table 23. Global Epilepsy Market Size Market Share by Region (2020-2025)
Table 24. Global Epilepsy Revenue by Country/Region (2020-2025) & ($ millions)
Table 25. Global Epilepsy Revenue Market Share by Country/Region (2020-2025)
Table 26. Americas Epilepsy Market Size by Country (2020-2025) & ($ millions)
Table 27. Americas Epilepsy Market Size Market Share by Country (2020-2025)
Table 28. Americas Epilepsy Market Size by Type (2020-2025) & ($ millions)
Table 29. Americas Epilepsy Market Size Market Share by Type (2020-2025)
Table 30. Americas Epilepsy Market Size by Application (2020-2025) & ($ millions)
Table 31. Americas Epilepsy Market Size Market Share by Application (2020-2025)
Table 32. APAC Epilepsy Market Size by Region (2020-2025) & ($ millions)
Table 33. APAC Epilepsy Market Size Market Share by Region (2020-2025)
Table 34. APAC Epilepsy Market Size by Type (2020-2025) & ($ millions)
Table 35. APAC Epilepsy Market Size by Application (2020-2025) & ($ millions)
Table 36. Europe Epilepsy Market Size by Country (2020-2025) & ($ millions)
Table 37. Europe Epilepsy Market Size Market Share by Country (2020-2025)
Table 38. Europe Epilepsy Market Size by Type (2020-2025) & ($ millions)
Table 39. Europe Epilepsy Market Size by Application (2020-2025) & ($ millions)
Table 40. Middle East & Africa Epilepsy Market Size by Region (2020-2025) & ($ millions)
Table 41. Middle East & Africa Epilepsy Market Size by Type (2020-2025) & ($ millions)
Table 42. Middle East & Africa Epilepsy Market Size by Application (2020-2025) & ($ millions)
Table 43. Key Market Drivers & Growth Opportunities of Epilepsy
Table 44. Key Market Challenges & Risks of Epilepsy
Table 45. Key Industry Trends of Epilepsy
Table 46. Global Epilepsy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 47. Global Epilepsy Market Size Market Share Forecast by Region (2026-2031)
Table 48. Global Epilepsy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 49. Global Epilepsy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 50. LivaNova Details, Company Type, Epilepsy Area Served and Its Competitors
Table 51. LivaNova Epilepsy Product Offered
Table 52. LivaNova Epilepsy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. LivaNova Main Business
Table 54. LivaNova Latest Developments
Table 55. Johnson & Johnson Services Details, Company Type, Epilepsy Area Served and Its Competitors
Table 56. Johnson & Johnson Services Epilepsy Product Offered
Table 57. Johnson & Johnson Services Epilepsy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Johnson & Johnson Services Main Business
Table 59. Johnson & Johnson Services Latest Developments
Table 60. Eisai Details, Company Type, Epilepsy Area Served and Its Competitors
Table 61. Eisai Epilepsy Product Offered
Table 62. Eisai Epilepsy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Eisai Main Business
Table 64. Eisai Latest Developments
Table 65. GlaxoSmithKline PLC Details, Company Type, Epilepsy Area Served and Its Competitors
Table 66. GlaxoSmithKline PLC Epilepsy Product Offered
Table 67. GlaxoSmithKline PLC Epilepsy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. GlaxoSmithKline PLC Main Business
Table 69. GlaxoSmithKline PLC Latest Developments
Table 70. Pfizer Details, Company Type, Epilepsy Area Served and Its Competitors
Table 71. Pfizer Epilepsy Product Offered
Table 72. Pfizer Epilepsy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Pfizer Main Business
Table 74. Pfizer Latest Developments
Table 75. UCB SA Details, Company Type, Epilepsy Area Served and Its Competitors
Table 76. UCB SA Epilepsy Product Offered
Table 77. UCB SA Epilepsy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. UCB SA Main Business
Table 79. UCB SA Latest Developments
Table 80. Medtronic PLC (Ireland) Details, Company Type, Epilepsy Area Served and Its Competitors
Table 81. Medtronic PLC (Ireland) Epilepsy Product Offered
Table 82. Medtronic PLC (Ireland) Epilepsy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Medtronic PLC (Ireland) Main Business
Table 84. Medtronic PLC (Ireland) Latest Developments
Table 85. NeuroPace Details, Company Type, Epilepsy Area Served and Its Competitors
Table 86. NeuroPace Epilepsy Product Offered
Table 87. NeuroPace Epilepsy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. NeuroPace Main Business
Table 89. NeuroPace Latest Developments
Table 90. Novartis AG Details, Company Type, Epilepsy Area Served and Its Competitors
Table 91. Novartis AG Epilepsy Product Offered
Table 92. Novartis AG Epilepsy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Novartis AG Main Business
Table 94. Novartis AG Latest Developments
Table 95. GW Pharmaceuticals Details, Company Type, Epilepsy Area Served and Its Competitors
Table 96. GW Pharmaceuticals Epilepsy Product Offered
Table 97. GW Pharmaceuticals Epilepsy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. GW Pharmaceuticals Main Business
Table 99. GW Pharmaceuticals Latest Developments
Table 100. Abbott Laboratories Details, Company Type, Epilepsy Area Served and Its Competitors
Table 101. Abbott Laboratories Epilepsy Product Offered
Table 102. Abbott Laboratories Epilepsy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Abbott Laboratories Main Business
Table 104. Abbott Laboratories Latest Developments
Table 105. Sanofi Details, Company Type, Epilepsy Area Served and Its Competitors
Table 106. Sanofi Epilepsy Product Offered
Table 107. Sanofi Epilepsy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Sanofi Main Business
Table 109. Sanofi Latest Developments
Table 110. Sunovion Pharmaceuticals Details, Company Type, Epilepsy Area Served and Its Competitors
Table 111. Sunovion Pharmaceuticals Epilepsy Product Offered
Table 112. Sunovion Pharmaceuticals Epilepsy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Sunovion Pharmaceuticals Main Business
Table 114. Sunovion Pharmaceuticals Latest Developments
Table 115. Bausch Health Details, Company Type, Epilepsy Area Served and Its Competitors
Table 116. Bausch Health Epilepsy Product Offered
Table 117. Bausch Health Epilepsy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Bausch Health Main Business
Table 119. Bausch Health Latest Developments
Table 120. Takeda Details, Company Type, Epilepsy Area Served and Its Competitors
Table 121. Takeda Epilepsy Product Offered
Table 122. Takeda Epilepsy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Takeda Main Business
Table 124. Takeda Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Epilepsy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Epilepsy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Epilepsy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Epilepsy Sales Market Share by Country/Region (2024)
Figure 8. Epilepsy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Epilepsy Market Size Market Share by Type in 2024
Figure 10. Epilepsy in Hospitals
Figure 11. Global Epilepsy Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Epilepsy in Neurology Centers
Figure 13. Global Epilepsy Market: Neurology Centers (2020-2025) & ($ millions)
Figure 14. Epilepsy in Home Care Settings
Figure 15. Global Epilepsy Market: Home Care Settings (2020-2025) & ($ millions)
Figure 16. Epilepsy in Ambulatory Surgical Centers
Figure 17. Global Epilepsy Market: Ambulatory Surgical Centers (2020-2025) & ($ millions)
Figure 18. Epilepsy in Others
Figure 19. Global Epilepsy Market: Others (2020-2025) & ($ millions)
Figure 20. Global Epilepsy Market Size Market Share by Application in 2024
Figure 21. Global Epilepsy Revenue Market Share by Player in 2024
Figure 22. Global Epilepsy Market Size Market Share by Region (2020-2025)
Figure 23. Americas Epilepsy Market Size 2020-2025 ($ millions)
Figure 24. APAC Epilepsy Market Size 2020-2025 ($ millions)
Figure 25. Europe Epilepsy Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Epilepsy Market Size 2020-2025 ($ millions)
Figure 27. Americas Epilepsy Value Market Share by Country in 2024
Figure 28. United States Epilepsy Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Epilepsy Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Epilepsy Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Epilepsy Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Epilepsy Market Size Market Share by Region in 2024
Figure 33. APAC Epilepsy Market Size Market Share by Type (2020-2025)
Figure 34. APAC Epilepsy Market Size Market Share by Application (2020-2025)
Figure 35. China Epilepsy Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Epilepsy Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Epilepsy Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Epilepsy Market Size Growth 2020-2025 ($ millions)
Figure 39. India Epilepsy Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Epilepsy Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Epilepsy Market Size Market Share by Country in 2024
Figure 42. Europe Epilepsy Market Size Market Share by Type (2020-2025)
Figure 43. Europe Epilepsy Market Size Market Share by Application (2020-2025)
Figure 44. Germany Epilepsy Market Size Growth 2020-2025 ($ millions)
Figure 45. France Epilepsy Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Epilepsy Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Epilepsy Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Epilepsy Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Epilepsy Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Epilepsy Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Epilepsy Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Epilepsy Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Epilepsy Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Epilepsy Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Epilepsy Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Epilepsy Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Epilepsy Market Size 2026-2031 ($ millions)
Figure 58. APAC Epilepsy Market Size 2026-2031 ($ millions)
Figure 59. Europe Epilepsy Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Epilepsy Market Size 2026-2031 ($ millions)
Figure 61. United States Epilepsy Market Size 2026-2031 ($ millions)
Figure 62. Canada Epilepsy Market Size 2026-2031 ($ millions)
Figure 63. Mexico Epilepsy Market Size 2026-2031 ($ millions)
Figure 64. Brazil Epilepsy Market Size 2026-2031 ($ millions)
Figure 65. China Epilepsy Market Size 2026-2031 ($ millions)
Figure 66. Japan Epilepsy Market Size 2026-2031 ($ millions)
Figure 67. Korea Epilepsy Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Epilepsy Market Size 2026-2031 ($ millions)
Figure 69. India Epilepsy Market Size 2026-2031 ($ millions)
Figure 70. Australia Epilepsy Market Size 2026-2031 ($ millions)
Figure 71. Germany Epilepsy Market Size 2026-2031 ($ millions)
Figure 72. France Epilepsy Market Size 2026-2031 ($ millions)
Figure 73. UK Epilepsy Market Size 2026-2031 ($ millions)
Figure 74. Italy Epilepsy Market Size 2026-2031 ($ millions)
Figure 75. Russia Epilepsy Market Size 2026-2031 ($ millions)
Figure 76. Egypt Epilepsy Market Size 2026-2031 ($ millions)
Figure 77. South Africa Epilepsy Market Size 2026-2031 ($ millions)
Figure 78. Israel Epilepsy Market Size 2026-2031 ($ millions)
Figure 79. Turkey Epilepsy Market Size 2026-2031 ($ millions)
Figure 80. Global Epilepsy Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Epilepsy Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Epilepsy Market Size 2026-2031 ($ millions)